A new trading day began on Friday, with Alx Oncology Holdings Inc (NASDAQ: ALXO) stock price down -10.34% from the previous day of trading, before settling in for the closing price of $0.45. ALXO’s price has ranged from $0.41 to $8.78 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -32.29%. Meanwhile, its annual earnings per share averaged 37.86%. With a float of $33.80 million, this company’s outstanding shares have now reached $53.38 million.
The extent of productivity of a business whose workforce counts for 80 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Alx Oncology Holdings Inc (ALXO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Alx Oncology Holdings Inc is 36.77%, while institutional ownership is 46.04%. The most recent insider transaction that took place on Feb 19 ’25, was worth 633. In this transaction SVP, FINANCE AND CAO of this company sold 550 shares at a rate of $1.15, taking the stock ownership to the 87,352 shares. Before that another transaction happened on Feb 19 ’25, when Company’s PRESIDENT & CSO sold 1,326 for $1.15, making the entire transaction worth $1,525. This insider now owns 579,388 shares in total.
Alx Oncology Holdings Inc (ALXO) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 37.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.05% during the next five years compared to -32.29% drop over the previous five years of trading.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Here are Alx Oncology Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.47, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.19 in one year’s time.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
The latest stats from [Alx Oncology Holdings Inc, ALXO] show that its last 5-days average volume of 1.31 million was superior to 0.8 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 6.35%.
During the past 100 days, Alx Oncology Holdings Inc’s (ALXO) raw stochastic average was set at 0.16%, which indicates a significant decrease from 0.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.89% in the past 14 days, which was lower than the 99.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5010, while its 200-day Moving Average is $1.1606. Now, the first resistance to watch is $0.4429. This is followed by the second major resistance level at $0.4801. The third major resistance level sits at $0.4995. If the price goes on to break the first support level at $0.3863, it is likely to go to the next support level at $0.3669. The third support level lies at $0.3297 if the price breaches the second support level.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Key Stats
With a market capitalization of 21.69 million, the company has a total of 53,396K Shares Outstanding. Currently, annual sales are 0 K while annual income is -134,850 K. The company’s previous quarter sales were 0 K while its latest quarter income was -30,750 K.
